Home/Filings/4/0000905148-25-000941
4//SEC Filing

Zaremba Rabourn Amy 4

Accession 0000905148-25-000941

CIK 0001228627other

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 8:54 PM ET

Size

7.2 KB

Accession

0000905148-25-000941

Insider Transaction Report

Form 4
Period: 2025-03-13
Zaremba Rabourn Amy
Head of Fin. Quality Assurance
Transactions
  • Award

    Common Stock

    2025-03-13+39,500113,968 total
  • Award

    Employee Stock Option (right to buy)

    2025-03-13+39,50039,500 total
    Exercise: $0.93Exp: 2035-03-12Common Stock (39,500 underlying)
Footnotes (2)
  • [F1]Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of March 13, 2025, subject to the Reporting Person's continuing service.
  • [F2]The option will vest with respect to 25% on March 13, 2026, with the remaining shares vesting quarterly in 12 equal installments thereafter at the end of each quarter, subject to the Reporting Person's continuing service.

Documents

1 file

Issuer

Opus Genetics, Inc.

CIK 0001228627

Entity typeother

Related Parties

1
  • filerCIK 0001832343

Filing Metadata

Form type
4
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 8:54 PM ET
Size
7.2 KB